Mucorales Endocarditis: A Case Series and Review of the Literature

Mucorales endocarditis is an extremely rare and devastating disease, with few cases reported in the literature. The infection is predominantly found in immunocompromised patients, although a few cases involving immunocompetent individuals have been reported. We reviewed all cases of mucor endocarditis reported to date with a focus on demographics, clinical presentations, and the range of predisposing conditions, including immunosuppressive states, recent surgery, and cardiac device implantation. The management included a combination of radical surgeries, systemic antifungal therapy, and, in some cases, lifelong suppressive oral antifungals. Despite such aggressive forms of treatment, the survival rate remained exceedingly low, reflecting the poor prognosis of this illness. The current review provides an insight into the clinical features, treatment challenges, and outcomes of mucor endocarditis to guide future diagnostic and therapeutic approaches.

Authors

Institutions

Publication Details

Journal
Cardiology in Review
Published
2025-09-05
DOI
https://doi.org/10.1097/crd.0000000000001026
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mucorales Endocarditis: A Case Series and Review of the Literature

Luis Tatem, Geurys Rojas-Marte, John Thottukadavil Eapen, Kuldeep Ghosh et al.
Cardiology in Review
Antifungal resistance and susceptibility
article

Mucorales Endocarditis: A Case Series and Review of the Literature

Luis Tatem, Geurys Rojas-Marte, John Thottukadavil Eapen, Kuldeep Ghosh, Marc Y. El Khoury, Sara Elattar, Thomas Pastorino
article en

Abstract

Mucorales endocarditis is an extremely rare and devastating disease, with few cases reported in the literature. The infection is predominantly found in immunocompromised patients, although a few cases involving immunocompetent individuals have been reported. We reviewed all cases of mucor endocarditis reported to date with a focus on demographics, clinical presentations, and the range of predisposing conditions, including immunosuppressive states, recent surgery, and cardiac device implantation. The management included a combination of radical surgeries, systemic antifungal therapy, and, in some cases, lifelong suppressive oral antifungals. Despite such aggressive forms of treatment, the survival rate remained exceedingly low, reflecting the poor prognosis of this illness. The current review provides an insight into the clinical features, treatment challenges, and outcomes of mucor endocarditis to guide future diagnostic and therapeutic approaches.

Cardiology in Review
Westchester Medical Center (US), New York Medical College (US)
Openalex Percentile: Top 71%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.